Hologic lowered its fiscal 2025 revenue forecast, citing weakness in sales of its breast health products, sending the company ...

Medical technology company Hologic (NASDAQ:HOLX) met Wall Street’s revenue expectations in Q4 CY2024, but sales were flat ...

Hologic Inc (HOLX) reports a 1% revenue increase with robust diagnostics performance, while facing headwinds in breast health ...

Raymond James lowered the firm’s price target on Hologic (HOLX) to $90 from $95 and keeps an Outperform rating on the shares. Hologic’s print ...

Hologic, Inc. HOLX reported adjusted earnings per share (EPS) of $1.03 in the first quarter of fiscal 2025, up 5.1% year over year. The metric surpassed the Zacks Consensus Estimate by 0.9%. Find the ...

Leerink downgraded Hologic (HOLX) to Market Perform from Outperform with a price target of $75, down from $80, following the fiscal Q1 report.

Q1 2025 Management View CEO Steve MacMillan announced Q1 2025 revenue of $1.022 billion, reflecting a 1% increase on a constant currency basis, aligned with the company’s guidance. Non-GAAP EPS ...

Q1 2025 Earnings Conference Call February 5, 2025 4:30 PM ETCompany ParticipantsMike Watts - Corporate Vice President, ...

Madison Keys, who captured her first Grand Slam title last month in Melbourne, has not played since her title-run Down Under.

Hologic (NASDAQ:HOLX – Get Free Report) will likely be issuing its quarterly earnings data after the market closes on ...

MARLBOROUGH, Mass. (AP) — MARLBOROUGH, Mass. (AP) — Hologic Inc. (HOLX) on Wednesday reported fiscal first-quarter profit of $201 million. On a per-share basis, the Marlborough, Massachusetts-based ...

Essex Mitchell; Chief Operating Officer; Hologic Inc Karleen Oberton; Chief Financial Officer; Hologic Inc Tycho Peterson; Analyst; Jeffries. Tejas Savant; Analyst; Morgan Stanley & Co. LLC Andrew ...